secretion and that uptake of Cl Ϫ across the basolateral membrane may be mediated by AE2. cystic fibrosis; anion exchanger 2; serous cell; submucosal gland; chloride transport; sodium bicarbonate cotransport AIRWAY EPITHELIAL CELLS REGULATE the volume and composition of airway surface fluid by mediating salt and water absorption and secretion (16, 32, 33) . Pulmonary mucocillary clearance is dependent on the thickness of the airway surface fluid and on the ability of cilia to propel mucus out of the lungs. Adequate mucocillary clearance is essential for the removal of inhaled particulate matter from the airways and is vital for the prevention of airway tract infection and obstruction. Submucosal glands play a major role in the secretion of airway surface fluid (9, 21, 44) . In particular, serous cells in human airway submucosal glands express high levels of cystic fibrosis transmembrane conductance regulator (CFTR), secrete Cl Ϫ and HCO 3 Ϫ , and fluid rich in antibiotic defensin and maganin peptides (8, 9, 15, 44) . Moreover, dysregulation of CFTR-mediated Cl Ϫ secretion in serous cells is thought to contribute to the pathophysiology of cystic fibrosis lung disease (9, 45) . However, the cellular mechanisms of fluid and electrolyte transport by human serous cells are incompletely understood. Recent studies on Calu-3 cells, a human airway cell line with a serous-cell phenotype, demonstrated that serous cells secrete Cl Ϫ and HCO 3 Ϫ by electrogenic processes (12, 17, 20, 24, 30, 36, 37) . HCO 3 Ϫ secretion is a two-step process: uptake across the basolateral membrane is mediated by a Na ϩ /HCO 3 Ϫ cotransporter (NBC), and exit from the cell is mediated by CFTR channels that are permeable to Cl Ϫ and HCO 3 Ϫ (12, 20, 24) . Cl Ϫ secretion is also a two-step process: uptake across the basolateral membrane is mediated by a Na ϩ /K ϩ /2Cl Ϫ cotransporter (NKCC1), and exit from the cell is mediated by CFTR Cl Ϫ channels (12, 17, 20, 26, 27, 30, 37) .
In many epithelia that secrete Cl Ϫ , the uptake of Cl Ϫ across the basolateral membrane is also mediated in part by Cl Ϫ /HCO 3 Ϫ exchange (1, 2, 13, 43) . The anion exchanger (AE, i.e., Cl Ϫ /HCO 3 Ϫ exchanger) gene family includes three structurally and functionally related anion exchangers: AE1, AE2, and AE3 (1, 2) . AE1 is expressed at highest levels in red blood cells and renal type A intercalated cells, AE2 is expressed broadly in epithelia, and AE3 is expressed in brain and heart, as well as in other excitable and some epithelial tissues. Recently, AE2 and bAE3 (brain AE3) mRNA were detected in human airways; however, the cell type and the subcellular location of AE2 and bAE3 in the airway is unknown (13) . Accordingly, the aim of the present study was to test the hypothesis that AEs are expressed in submucosal glands, particularly in serous cells, and that AEs contribute to transepithelial Cl Ϫ secretion. To this end, we studied Calu-3 cells, a human airway cell line with a serous-cell phenotype (17, 20, 27, 30, 36, 37) , and characterized the possible role of AEs in Cl Ϫ secretion by RT-PCR, Western blot analysis, and electrophysiological analysis. In addition, we examined the cellular location of AE proteins in Calu-3 and rat serous cells by immunofluoresence microscopy. We report that a small component of 8-(4-chlorophenylthio)adenosine 3Ј,5Ј-cyclic monophosphate (CPTcAMP)-stimulated short-circuit anion current (I sc ) across Calu-3 cells may be referable to Cl Ϫ secretion and that Cl Ϫ uptake across the basolateral membrane may be mediated in part by AE2.
METHODS
Cell culture. Calu-3 cells were obtained at pass 17 from the American Type Culture Collection (HTB-55; Rockville, MD) and grown in air-interface culture (i.e., cell culture media added only to the basolateral side of cells grown on Millicell PCF filters) as described in detail previously (26, 27) .
Measurement of I sc . I sc was measured by placing monolayers grown on Millicell polycarbonate (PCF) filters for 14-28 days in culture into an Ussing-type chamber (Jim's Instrument, Iowa City, IA) as described previously (26, 27) . Bath solutions were maintained at 37°C and were stirred by bubbling with 5% CO 2 air (CO 2 /HCO 3 Ϫ -containing solutions) or room air (CO 2 /HCO 3 Ϫ -free solutions). In Ussing chamber studies, cells were bathed in either a control solution containing (in mM) 116 NaCl, 24 NaHCO 3 , 3 KCl, 2 MgCl 2 , 0.5 CaCl 2 , 3.6 NaHEPES and 4.4 HHEPES (pH 7.4) or a 0Na ϩ solution containing (in mM) 116 NMDGCl, 24 choline HCO 3 , 3 KCl, 2 MgCl 2 , and 0.5 CaCl 2 (pH 7.4). These solutions were gassed with 5% CO 2 balance air. In some studies, monolayers were bathed in a nominally Na ϩ and CO 2 /HCO 3 Ϫ -free solution containing (in mM) 140 NMDGCl, 3 KCl, 2 MgCl 2 , 0.5 CaCl 2 , 3.6 NaHEPES, and 4.4 HHEPES (pH 7.4), gassed with room air, and including acetazolamide (100 M) to inhibit the endogenous production of HCO 3 Ϫ . Western blot analysis. Cell monolayers grown on Millicell filters and/or tissue culture flasks were solubilized in lysis buffer [50 mM Tris ⅐ HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, and containing Complete Protease Inhibitor cocktail (Boehringer Mannheim, Indianapolis, IN)] for 60 min at 4°C and spun at 14,000 g for 4 min to pellet insoluble material. Supernatants were separated on 4-20% Tris ⅐ HCl gradient gels (Bio-Rad) and transferred to polyvinylidene difluoride Immobilon membranes (Millipore, Bedford, MA). Membranes were blocked overnight at 4°C in 5% nonfat dry milk in Tris-buffered saline/0.02% Tween 20 and incubated with an affinity-purified polyclonal antibody (SA6) against the COOH-terminal 12 amino acids (1,224-1,237) of mouse AE2 (165 kDa). This antibody cross-reacts with another member of the AE anion exchanger family, AE1 (100-115 kDa), but does not recognize AE3 (at a 1:10,000 dilution) (3, 5, 6) . After incubation with the primary antibody, blots were incubated with an anti-rabbit horseradish peroxidase-conjugated secondary antibody (1:5,000; Amersham, Arlington Heights, IL). Blots were developed by enhanced chemiluminescence using Hyperfilm ECL (Amersham). Other primary antibodies used to detect AEs included affinity-purified polyclonal antibodies against the COOH terminus of AE3 (SA8) and the cytoplasmic terminus of cardiac AE3 (cAE3; antibody no. SA17) (7) .
Laser scanning confocal fluorescence microscopy. Calu-3 cells were grown on Millicell PCF filters and were fixed and processed for laser scanning confocal fluorescence microscopy as previously described (26, 27) . Briefly, cells were fixed with 3% paraformaldehyde for 15 min at room temperature and subsequently embedded into cryoembedding compound (Microm, Walldorf, Germany). Rat tracheas were harvested from four adult male Wistar rats (BRL, Fü llinsdorf, Switzerland) that weighed ϳ180 g. The rats were anaesthetized with 100 mg/kg body wt of thiopental (Pentothal; Abbott, Cham, Switzerland), and the tracheas were fixed by intravascular perfusion through the abdominal aorta. The fixative solution consisted of 3% paraformaldehyde and 0.05% picric acid in a 6:4 mixture of 0.1 M cacodylate buffer (pH 7.4, adjusted to 300 mosmol/kgH 2 O with sucrose) and 10% hydroxyethyl starch in saline (HAES steril; Fresenius, Stans, Switzerland). After 5 min of fixation, the fixative was washed out for 5 min with the cacodylate-buffered solution. Tracheas were removed, cut into ϳ2-mm-thick slices horizontal to the long axis, and embedded into cryoembedding compound. Embedded Calu-3 cells and tracheas were frozen in liquid propane and stored at Ϫ80°C. Six-micrometer-thick sections of frozen Calu-3 cells and rat tracheas were cut in a cryostat and placed on chrome alum gelatin-coated glass slides. After SDS-antigen retrieval [i.e., preincubation of the sections with 1% SDS for 10 min (11)], nonspecific binding sites were blocked with 10% normal goat serum (DAKO, Glostrup, Denmark) in PBS. Subsequently, sections were incubated with 1:500-1:1,000 dilutions of polyclonal AE antibodies (described above) in PBS with 0.5% BSA (PBS-BSA) for 1 h at room temperature. After repeated washings with PBS, binding sites of the secondary antibody were revealed with a FITC-conjugated swine-anti-rabbit IgG (DAKO) diluted 1:40 in PBS-BSA. To identify cell nuclei, nucleic acids were stained with propidium iodide (2.5 g/ml). Sections were mounted in DAKO-Glycergel (DAKO) that contained 2.5% 1,4-diazabicyclo[2.2.2]octane to retard fading. Fluorescent images were acquired using a Zeiss Axioskop microscope (Thornwood, NY) equipped with a laser scanning confocal unit (model MRC-1024; Bio-Rad Labs, Hercules, CA), a 15-mW krypton-argon laser, and a ϫ63 PlanApochromat/1.4 numerical aperture (NA) or ϫ40 PlanNeofluor/1.3 NA oilimmersion objective. FITC fluorescence was excited using the 488-nm laser line and collected using a standard FITC filter set (530 Ϯ 30 nm). Propidium iodide fluorescence was excited using the 568-nm laser line and collected using a standard Texas Red filter set (605 Ϯ 32 nm). Acquired images were imported into Adobe Photoshop version 3.0 for image processing and printing.
RT-PCR. mRNA was prepared from cells grown to confluency on Millicell PCF filters using the FastTrack 2.0 kit (Invitrogen, Carlsbad, CA). Reverse transcription was performed with the First Strand DNA synthesis kit from Ambion. Each synthesis was loaded with 40 ng mRNA (estimated to correspond to 1 g total RNA), and one-twentieth aliquots of the RT reaction were used in PCR reactions of 50 l final volume. PCR was performed by the hot start procedure using Taq DNA polymerase (Promega) in the supplier's recommended buffer.
PCR mixes lacking only primers were preheated at 82°C for 1 min, and then gene-specific primers (Table 1) were injected into the mix through oil. The complete reaction mixes were denatured for 3 min at 95°C and then cycled through these conditions: denaturation for 45 s at 94°C, annealing for 2 min at 60°C, and elongation for 2 min at 72°C. Final extension of 10 min at 72°C was terminated by rapid cooling to 4°C after 35 cycles. PCR products were separated and analyzed in 1% agarose gels and sequenced to confirm their identities as specific AE cDNA fragments (ABI 373; Applied Biosystems, Foster City, CA).
Statistical analysis. Differences between means were compared by either unpaired Student's t-tests or by analysis of variance followed by Bonferroni multiple-comparisons test as appropriate. All analyses were performed with the InStat statistical software package (Graphpad, San Diego, CA). Data are expressed as the means Ϯ SE. P Ͻ 0.05 was considered significant.
RESULTS

Molecular identification of AE isoforms in Calu-3 cells.
By RT-PCR, we determined that Calu-3 cells express mRNA for AE2 and low levels of mRNA for bAE3. AE1 and cAE3 transcripts could not be detected in Calu-3 cells (Fig. 1) . Negative controls for RT-PCR included omission of cDNA from the reaction and yielded no product (data not shown). Positive controls for AE1 and cAE3, including rat kidney and reticulocyte (AE1) and heart and placenta (cAE3), were positive (Fig. 1) . Thus Calu-3 cells express mRNA for AE2 and bAE3.
Western blot analysis of AE isoforms in Calu-3 cells.
Three independent preparations of Calu-3 cells were assessed by immunoblot for the presence of AE1, AE2, and AE3 polypeptides. As shown in Fig. 2 , a 165-kDa polypeptide was detected by an antibody to the COOH terminus of AE2 (SA6). The 165-kDa protein corresponding to AE2 was not detected when antibody incubations were conducted in the presence of the immunizing peptide antigen. As expected, on the basis of our RT-PCR studies, a polypeptide of the appropriate molecular mass (100-115 kDa) could not be detected with a mouse monoclonal antibody to rat AE1 (data not shown). Although mRNA for bAE3 was identified, the expression of AE3 polypeptide could not be detected by immunoblot analysis using two different polyclonal antibodies (data not shown). Thus either Calu-3 cells do not express AE3 polypeptide, or the level of AE3 expression was below the sensitivity of our immunoblot analysis. Taken together, our RT-PCR and Western blot studies demonstrate that Calu-3 cells express AE2 mRNA and AE2 polypeptide.
Immunolocalization of AE isoforms in Calu-3 and rat tracheal epithelia. Immunocytochemical localization of AE isoforms in Calu-3 cells and rat trachea was performed using the same anti-AE antibodies that were used for Western blot analysis. All Calu-3 cells and serous acinar cells of rat submucosal glands examined R, b) ; there is no mismatch with mouse and rat AE3. Each primer pair was selected so as to be separated in the genome by at least 2 introns. AE, anion exchanger; F, forward primer; R, reverse primer; Acc No., GenBank Accession number of the cDNA sequence. Fig. 1 . RT-PCR analysis of mRNA in Calu-3 cells compared with positive control human tissues including kidney and reticulocytes (Retic). Calu-3 cells expressed anion exchanger (AE2) mRNA and low levels of brain AE3 (bAE3) mRNA. AE1 and cardiac AE3 (cAE3) transcripts, however, were undetectable in Calu-3 cells. Fig. 2 . Representative Western blots using anti-AE2 polyclonal antibody (SA6: 1,000 dilution). A single 165-kDa band was observed with SA6 but not when the immunizing peptide (1:500 dilution from a stock of 1.2 mg/ml) was included in the incubation buffer. AE proteins were not detected when the blots were probed with antibodies (Ab) that recognize AE3 (SA8 and SA17) or AE1 (negative blots not shown). Equal amounts of protein (150 g/lane) were added to each well of the gel. See METHODS for details on the experimental protocol.
had detectable AE2 polypeptide that was localized to the basolateral plasma membrane (Fig. 3, E and F) . Furthermore, AE2 was seen in the basolateral membrane of some ciliated surface epithelial cells but not in the epithelial cells lining the ducts of submucosal glands (Fig. 3, A-D) . AE2 was not detected when antibody incubations were conducted in the presence of the immunizing peptide. Consistent with our RT-PCR and Western blot studies, AE1 polypeptide was not detected in Calu-3 cells or rat submucosal glands using a monoclonal antibody specific for AE1 (14) . However, as a positive control, the AE1 antibody did stain intercalated cells in rat kidney as demonstrated previously (Ref. 3 ; results not shown). Thus Calu-3 and rat submucosal gland cells express AE2 polypeptide in the basolateral but not the apical plasma membrane.
Electrophysiological studies: an AE in the apical membrane does not contribute to I sc in Calu-3 cells. To determine if AEs contribute to anion secretion by Calu-3 cells, monolayers were mounted in an Ussing chamber, and the CPT-cAMP-stimulated I sc was measured. In Calu-3 cells, I sc is referable to electrogenic Cl Ϫ and/or HCO 3 Ϫ secretion (12, 17, 20, 26, 27, 30, 36, 37) . Our immunolocalization studies suggest that AE2 is expressed in the basolateral but not the apical membrane; however, it is possible that an AE is present in the apical membrane, but it cannot be detected by immunofluorescence microscopy. For example, a functionally defined AE has been detected in the apical membrane of ␤-intercalated cells in the renal cortical collecting duct, but this AE cannot be detected with antibodies to AE1 or AE2 (3, 6, 40) . Thus to explore the possibility that functional AEs are present in the apical membrane, we determined whether the anion exchange inhibitors 4,4Ј-diisothiocyanostilbene-2,2Ј-disulfonic acid (DIDS) and 4,4Ј-dinitrostilbene-2,2Ј-disulfonic acid (DNDS), which inhibit Cl Ϫ /HCO 3 Ϫ exchange (1), and dibenzamidostilbene disulfonic acid (DBDS), which inhibits Cl Ϫ /OH Ϫ exchange (41), reduced I sc . Although AEs are electroneutral, inhibition of AE activity would be expected to alter I sc indirectly by changing the intracellular activities of Cl Ϫ and HCO 3 Ϫ , and thus the electrochemical driving force for Cl Ϫ and HCO 3 Ϫ exit across the apical plasma membrane. Neither DIDS, DNDS, nor DBDS altered I sc when added to the apical bath solution (Table 2) . Thus we could not detect stilbene-sensitive AEs in the apical membrane of Calu-3 cells by indirect immunofluoresence microscopy or by electrophysiological techniques.
Electrophysiological studies: an AE in the basolateral membrane contributes to I sc in Calu-3 cells. Ussing chamber studies were conducted to provide functional evidence for an AE in the basolateral membrane of Calu-3 cells. We examined the ability of the AE inhib- (Fig. 4) . DNDS (500 M) also inhibited CPT-cAMP-stimulated I sc but, unlike DIDS, did not reduce I sc to basal levels (Figs. 4 and 5A). DIDS inhibits AE and the Na ϩ /HCO 3 Ϫ cotransporter (i.e., NBC). The EC 50 for DIDS inhibition of AE2 is 3-15 M (14, 18), whereas DIDS inhibition of NBC requires significantly higher concentrations (i.e., 500 M) (10, 35) . Accordingly, the observation that 50 M DIDS completely inhibited CPT-cAMP-stimulated I sc is consistent with the view that an AE in the basolateral membrane contributes to CPT-cAMP-stimulated I sc . However, we cannot formally exclude the possibility that DIDS also reduced I sc , in part, by inhibiting NBC in the basolateral membrane. Thus additional studies were conducted to determine whether a Na ϩ -independent AE (i.e., Cl Ϫ /HCO 3 Ϫ exchanger) is present in the basolateral membrane of Calu-3 cells (12) .
To provide additional support for the view that AE2 in the basolateral membrane contributes to CPTcAMP-stimulated I sc , we removed Na ϩ from the apical and basolateral bath solutions to eliminate the possible contribution of NBC and NKCC1 to I sc . In the absence of Na ϩ in the bath solutions, CPT-cAMP increased I sc from 3.1 Ϯ 0.6 A/cm 2 to 10.6 Ϯ 1.2 A/cm 2 (P Ͻ 0.01; n ϭ 4 monolayers per group; Fig. 5B ). DNDS (500 M), an AE inhibitor, completely blocked the CPT-cAMPstimulated increase in I sc [I sc was 3.1 Ϯ 0.6 A/cm 2 before addition of CPT-cAMP and 2.6 Ϯ 0.6 A/cm 2 (P Ͻ 0.01) after addition of CPT-cAMP; n ϭ 4 monolayers per group; Fig. 5B ]. If the CPT-cAMP-stimulated I sc is mediated by AE2 located in the basolateral membrane, removal of HCO 3 Ϫ from the 0Na ϩ bath solutions should eliminate the contribution of AE2 to the CPT-cAMP-stimulated I sc . When monolayers were bathed in Na ϩ -and HCO 3 Ϫ -free solutions, CPT-cAMP failed to increase I sc (I sc was 2.3 Ϯ 0.4 A/cm 2 before CPT-cAMP and 3.7 Ϯ 0.8 A/cm 2 after CPT-cAMP; n ϭ 4 monolayers per group). Taken together, these observations support the view that a small component of CPT-cAMP-stimulated I sc across Calu-3 cells may be 
Values are means Ϯ SE. Basal I sc was 25.7 Ϯ 2.4 A/cm 2 (n ϭ 5/ experimental group). CPT-cAMP, 8-(4-chlorophenylthio)adenosine 3Ј,5Ј-cyclic monophosphate; DIDS, 4,4Ј-diisothiocyanostilbene-2,2Ј-disulfonic acid; DNDS, 4,4Ј-dinitrostilbene-2,2Ј-disulfonic acid; DBDS, dibenzamidostilbene disulfonic acid; I sc , short-circuit anion current. Fig. 4 . Effects of AE inhibitors 4,4Ј-diisothiocyanostilbene-2,2Ј-disulfonic acid (DIDS) and 4,4Ј-dinitrostilbene-2,2Ј-disulfonic acid (DNDS) on 8-(4-chlorophenylthio)adenosine 3Ј,5Ј-cyclic monophosphate (CPT-cAMP)-stimulated short-circuit anion current (I sc ; y-axis in A/cm 2 ). Basal represents the I sc before addition of CPT-cAMP (100 M) to the apical and basolateral solutions. DIDS (50 M) and DNDS (500 M) were added to the basolateral solution after CPTcAMP treatment. Higher concentrations of DNDS (1 and 3 mM) had no additional inhibitory effect on CPT-cAMP-stimulated I sc [69.0 Ϯ 4.2 A/cm 2 (no DNDS), 49.9 Ϯ 2.1 A/cm 2 (500 M DNDS), 48.5 Ϯ 2.8 A/cm 2 (1 mM DNDS), and 49.5 Ϯ 6.0 A/cm 2 (3 mM DNDS); n ϭ 6 monolayers per group]. *P Ͻ 0.05 vs. CPT-cAMP alone. **P Ͻ 0.05 vs. basal. As demonstrated previously (26, 27) , the CPT-cAMPstimulated I sc reached a peak value after ϳ2 min. referable to Cl Ϫ secretion and that Cl Ϫ uptake across the basolateral membrane may be mediated in part by AE2.
DISCUSSION
The major new findings in this report are that Calu-3 and serous cells in rat submucosal glands express AE2 in the basolateral membrane and that AE2 may contribute to electrogenic anion secretion across Calu-3 cells.
AE2 is expressed in the basolateral membrane of Calu-3 and serous cells in rat submucosal glands. Five lines of evidence in this report support the view that AE2 is expressed in Calu-3 cells: 1) abundant AE2 mRNA was detected by RT-PCR; 2) AE2 polypeptide was detected by Western blot analysis; 3) AE2 was localized to the basolateral membrane by indirect immunofluoresence; 4) in the absence of Na ϩ , to eliminate the contribution of the NBC and NKCC1 to I sc , CPTcAMP stimulated DNDS-sensitive I sc , and 5) DIDS, at a concentration well above the EC 50 for AE2 (i.e., 4 M) (14, 18, 19) and AE3 (23) , inhibited the CPT-cAMPstimulated I sc . In addition, AE2 was identified in the basolateral membrane of rat serous cells in airway submucosal glands. Thus AE2 was identified in the basolateral membrane of rat serous cells in vivo and in Calu-3 cells, a human airway cell line with a serouscell phenotype (12, 17, 20, 30, 36, 37) .
Neither pharmacological nor indirect immunofluoresence techniques identified AE2 in the apical membrane of Calu-3 or rat serous cells, in agreement with a recent study (37) . Moreover, we did not find any evidence for AE1 expression in Calu-3 or rat serous cells. cAE3 mRNA was not expressed in Calu-3 cells; however, low levels of bAE3 mRNA were detected by RT-PCR. These observations are in agreement with a recent study in which AE2 and bAE3 mRNA was detected in human airways; however, the cell type expressing these AEs and the subcellular location of AE polypeptide was not determined (13) . Thus our results extend these observations by localizing AE2 to the basolateral membrane of serous cells in the submucosal gland. Although mRNA for bAE3 was identified in Calu-3 cells, the expression of AE3 polypeptide could not be detected by immunoblot analysis using two different polyclonal antibodies. Thus Calu-3 cells may not express AE3 polypeptide. Alternatively, the level of AE3 polypeptide expression in the Calu-3 cell line may be below the sensitivity of our immunoblot analysis.
AE2 has been localized to the basolateral membrane, but not the apical membrane, of numerous polarized epithelial cells including epididymis, stomach, small and large intestines, salivary glands, cochlea, vestibular apparatus, and alveolar type II cells (2, 5, 6, 11, 31, 39, 40, 47) . bAE3 has been identified in the basolateral membranes of renal tubular cells (7) and has been observed on both basolateral and apical membranes of ileal and jejunal enterocytes (Stuart-Tilley, Wilhelm, and Alper, unpublished observations). cAE3 is expressed in the apical and basolateral membranes of renal epithelial cells, gut, and choroid plexus epithelia (Stuart-Tilley, Wilhelm, and Alper, unpublished observations). Thus although there is precedent for AE expression in apical membranes, our studies did not support the presence of an AE in the apical membrane of Calu-3 cells or in rat serous cells in situ.
cAMP-stimulated I sc in Calu-3 cells. In a previous study on Calu-3 cells, it was deduced from ion substitution studies that forskolin-stimulated (i.e., cAMPstimulated) I sc was referable to electrogenic HCO 3 Ϫ secretion driven by a DNDS-sensitive, Na ϩ -and HCO 3 Ϫ -dependent cotransporter (i.e., NBC) located in the basolateral membrane (12) . Removal of HCO 3 Ϫ or Na ϩ from the bath solutions dramatically reduced the forskolin-stimulated I sc . Data in the present study confirm the conclusion that the majority of cAMP-stimulated I sc is referable to NBC-driven HCO 3 Ϫ secretion in Calu-3 cells (12) . We observed that removal of Na ϩ from the bath solutions dramatically reduced the CPTcAMP-stimulated increase in I sc from 44.5 to 7. , to the electrochemical gradient for each ion across the apical membrane, the rate of Cl Ϫ and HCO 3 Ϫ uptake across the basolateral membrane, and the agonist stimulating anion transport (12) . Although the stochiometry of Na ϩ and HCO 3 Ϫ for NBC in Calu-3 cells has not been determined, it is likely to operate in a 1Na ϩ /2HCO 3 Ϫ mode that would favor Na ϩ /HCO 3 Ϫ entry into the cell across the basolateral membrane (12, 34 36 efflux from Calu-3 cells and that the cAMP-stimulated increase in I sc is equivalent to the increase in Cl 36 flux from the serosal to the mucosal solution across Calu-3 cells (22, 25, 36) . Moreover, in a recent study, removal of Cl Ϫ from the bath solutions reduced forskolin-stimulated I sc across Calu-3 cells (from 66 to 46 A/cm 2 ), an observation consistent with the view that cAMP stimulates some Cl Ϫ secretion across Calu-3 cells (12) . On the other hand, some laboratories report that cAMP does not stimulate Cl Ϫ secretion across Calu-3 cells (12, 24) . Thus the effects of cAMP on Cl Ϫ secretion across Calu-3 cells are controversial.
Cell model of electrogenic anion secretion by serous cells. Figure 6 is a cellular model illustrating the cellular location of transport proteins identified in Calu-3 and serous cells that are relevant to Cl Ϫ and HCO 3 Ϫ transport. The location of these transport proteins can account for Cl Ϫ and HCO 3 Ϫ secretion across serous cells in vivo (8) . CFTR Cl Ϫ channels are located in the apical membrane, and NKCC1, Na ϩ -K ϩ -ATPase, NBC, and K ϩ channels are expressed in the basolateral membrane (12, 17, 20, 26, 27, 30, 37) . In the present study, we have demonstrated that AE2 is also expressed in the basolateral membrane. According to this model, cAMP-stimulated HCO 3 Ϫ secretion is a two-step process: uptake across the basolateral membrane is mediated by NBC, and CFTR channels in the apical membrane mediate HCO 3 Ϫ exit from the cell (12, 20, 24) . Cl Ϫ secretion is also a two-step process: uptake across the basolateral membrane is mediated by NKCC1, and Cl Ϫ exit from the cell is mediated by CFTR Cl Ϫ channels (12, 17, 20, 26, 27, 30, 37) . In addition, the data in this manuscript are consistent with the conclusion that a small fraction of the cAMP-stimulated increase in I sc may be referable to Cl Ϫ secretion. We propose that Cl Ϫ uptake across the basolateral membrane is mediated by AE2, and Cl Ϫ exits the cell through CFTR Cl Ϫ channels in the apical membrane. We cannot exclude the possibility that AE2 may also contribute to the regulation of intracellular pH. The relative importance of each transport pathway to electrogenic anion secretion is uncertain and may be dependent on the agonist stimulating the secretion. However, this model is consistent with observations in native tissue that cAMP stimulates Cl Ϫ and HCO 3 Ϫ secretion by submucosal glands (8, 38) .
